Last month, April, 2002, I reviewed the malpractice crisis US ob/gyns are facing. What steps can be taken to address the current situation and how do we craft a long-term strategy to create a fair and impartial method of adjudicating malpractice claims?
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
FDA grants Priority Review to flibanserin for treating postmenopausal HSDD
July 24th 2025The FDA has granted Priority Review to expand flibanserin (Addyi; Sprout Pharmaceuticals) use to postmenopausal women, potentially broadening access to treatment for hypoactive sexual desire disorder.
Read More